The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial (Q42781348)
Jump to navigation
Jump to search
scientific article published on December 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial |
scientific article published on December 2010 |
Statements
1 reference
The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial (English)
1 reference
Anders Bonde Jensen
1 reference
Christopher Wynne
1 reference
Guillermo Ramirez
1 reference
Weili He
1 reference
Yang Song
1 reference
Yuliya Berd
1 reference
Hongwei Wang
1 reference
Anish Mehta
1 reference
Antonio Lombardi
1 reference
1 December 2010
1 reference
1 reference
10
1 reference
6
1 reference
452-458
1 reference
Identifiers
1 reference
1 reference